Court Of Appeals Affirms Favorable Decision Regarding Generic Prevacid(R) SoluTab
Main Category: Pharma Industry / Biotech IndustryArticle Date: 25 Jan 2010 - 3:00 PDT
email to a friend 
printer friendly 
opinions
| Patient / Public: |  | |
| Healthcare Prof: | |
Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the U.S. Court of Appeals for the Federal Circuit has affirmed a Nov. 10, 2009, District Court decision that the Company's generic version of Takeda's Prevacid® (lansoprazole) SoluTab does not infringe U.S. Patent No. 5,464,632.
Teva's Abbreviated New Drug Application (ANDA) to market lansoprazole orally disintegrating tablets is currently pending final approval at the U.S. Food and Drug Administration (FDA).
Annual sales of the brand product were approximately $513 million in the United States based on IMS sales data.
Source
Teva Pharmaceutical Industries Ltd.
Visit our pharma industry / biotech industry section for the latest news on this subject.
MLA
13 Feb. 2012. <http://www.medicalnewstoday.com/releases/177006.php>
APA
http://www.medicalnewstoday.com/releases/177006.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
Privacy Policy |
Terms and Conditions
MediLexicon International Ltd
Bexhill-on-Sea, United Kingdom
MediLexicon International Ltd © 2004-2012 All rights reserved.
